|
Q3 FY2026
As of Jul 31, 2026
|
Q2 FY2026
As of Apr 30, 2026
|
Q1 FY2026
As of Jan 31, 2026
|
Q4 FY2025
As of Oct 31, 2025
|
Q3 FY2025
As of Jul 31, 2025
|
Q2 FY2025
As of Apr 30, 2025
|
Q1 FY2025
As of Jan 31, 2025
|
Q4 FY2024
As of Oct 31, 2024
|
Q3 FY2024
As of Jul 31, 2024
|
Q2 FY2024
As of Apr 30, 2024
|
Q1 FY2024
As of Jan 31, 2024
|
Q4 FY2023
As of Oct 31, 2023
|
Q3 FY2023
As of Jul 31, 2023
|
Q2 FY2023
As of Apr 30, 2023
|
Q1 FY2023
As of Jan 31, 2023
|
Q4 FY2022
As of Oct 31, 2022
|
Q3 FY2022
As of Jul 31, 2022
|
Q2 FY2022
As of Apr 30, 2022
|
Q1 FY2022
As of Jan 31, 2022
|
Q4 FY2021
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Property, construction, and office equipment – net | ||||||||||||||||||||
| Receivables, prepaid expenses, and other assets | ||||||||||||||||||||
| Real estate and related assets held for sale | ||||||||||||||||||||
| Mortgage loans held for sale – at fair value | ||||||||||||||||||||
| Customer deposits held in escrow | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total investments in unconsolidated entities | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Senior notes | ||||||||||||||||||||
| Mortgage company loan facility | ||||||||||||||||||||
| Customer deposits | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Liabilities related to assets held for sale | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Preferred stock, none issued | ||||||||||||||||||||
| Common stock, 102,937 shares issued at July 31, 2026 and October 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital ("APIC") | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost —10,569 and 8,140 shares at July 31, 2026 and October 31, 2025, respectively | ||||||||||||||||||||
| Accumulated other comprehensive income ("AOCI") | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Assets related to consolidated VIEs | ||||||||||||||||||||
Loading...
